Shareholder Alert: Ademi LLP investigates whether AVEO Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with LG Chem
prnewswire.com
news
2022-10-18 14:30:00

MILWAUKEE, Oct. 18, 2022 /PRNewswire/ -- Ademi LLP is investigating AVEO (NASDAQ: AVEO) for possible breaches of fiduciary duty and other violations of law in its transaction with LG Chem. 
Click here to learn how to join the action https://www.ademilaw.com/case/aveo-pharmaceuticals-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges AVEO's financial outlook and prospects are excellent and yet AVEO holders will receive only $15.00 per share in an all-cash transaction with an implied equity value of $566 million on a fully diluted basis.
